Request Demo
Last update 28 Jun 2025
Azelnidipine/Telmisartan
Last update 28 Jun 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Telmisartan/azelnidipine |
Action antagonists, blockers |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC33H30N4O2 |
InChIKeyRMMXLENWKUUMAY-UHFFFAOYSA-N |
CAS Registry144701-48-4 |
View All Structures (2)
Related
3
Clinical Trials associated with Azelnidipine/TelmisartanCTRI/2023/07/055818
A Prospective, Randomized, Open label, Investigator Initiated academic clinical trial to evaluate theefficacy and safety of FDC of Azelnidipine and Telmisartan as compared to FDC of Amlodipine andTelmisartan in Indian Essential Hypertensive Patients - NIL
CTRI/2022/07/044031
A multicentric randomized double blind parallel group two arm comparative phase III clinical study to evaluate the efficacy safety and tolerability of FDC of Azelnidipine 16 mg plus Telmisartan 40 mg Film Coated Tablets Versus FDC of Amlodipine 5 mg plus Telmisartan 40 mg tablets in subjects with stage 2 hypertension
CTRI/2022/05/042428
An Open label, balanced, randomized, two-treatment, twoperiod,two-sequence, single oral dose, crossover,bioequivalence study of FDC of Azelnidipine 8 mg +Telmisartan 40 mg tablet of Signature PhytochemicalIndustries with Uniaz T 40mg tablet (Azelnidipine 8 mg +Telmisartan 40 mg) of Synokem Pharmaceuticals Ltd., inhealthy adult human subjects under fasting conditions.
100 Clinical Results associated with Azelnidipine/Telmisartan
Login to view more data
100 Translational Medicine associated with Azelnidipine/Telmisartan
Login to view more data
100 Patents (Medical) associated with Azelnidipine/Telmisartan
Login to view more data
100 Deals associated with Azelnidipine/Telmisartan
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertension | Phase 3 | India | 28 Dec 2019 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free